
    
      Change of circulating and tissular dendritic cells of patients with acute lung injury was
      still unclear, we used a flow cytometry-based assay to quantify circulating and tissular DCs
      and their HLA-DR surface expression at the time of diagnosis and during the first week of
      evolution in patients with acute lung injury, and healthy people as controls.
    
  